Technology | Contrast Media | November 02, 2015

Access Scientific Powerwand Validated for CT Contrast Injection

4Fr and 5Fr Powerwands now ideal for virtually all CT contrast studies

Access Scientific, Powerwand midline IV catheter, CT contrast injection

Image courtesy of Access Scientific LLC

November 2, 2015 — Access Scientific LLC announced validation of the Powerwand midline IV catheter for power-injectable capability up to 8ml/sec, 325 psi for up to 10 cycles. The addition of this performance capability makes both 4Fr and 5Fr Powerwands ideal for virtually all computed tomography (CT) contrast studies, to meet the most demanding injection protocols.

The Powerwand now combines high power injectability with a low total complication rate, high flow rates and high rate for completion of therapy. Moreover, in peer-reviewed published studies and scientific posters, the Powerwand has consistently exhibited kink-resistance and blood drawability, making one-stick hospitalizations not only possible but also common.

The catheter combines ChronoFlex C material with Access Scientific’s proprietary kink-resistant process for enhanced performance.

For more information: www.accessscientific.com

Related Content

Hitachi Supria True64 CT Receives FDA Clearance
Technology | Computed Tomography (CT)| September 15, 2017
Hitachi Healthcare Americas Inc. announced it has attained U.S. Food and Drug Administration (FDA) 510(k) clearance to...
Orange County, Calif. Hospital Adopts Siemens Somatom Force CT for Cardiac Imaging
News | Computed Tomography (CT)| September 12, 2017
Hoag Memorial Hospital Presbyterian recently became the first hospital in Orange County, Calif., to install the Siemens...
Technology | Radiation Dose Management| September 07, 2017
September 7, 2017 — Sapheneia and Scannerside received U.S.
FDA Holds MIDAC Meeting on Gadolinium-Based Contrast Agents. Image by Marilyn Fornell
News | Contrast Media| September 07, 2017
The U.S. Food and Drug Administration (FDA) announced it would hold a meeting of the Medical Imaging Drugs Advisory...
European Medicines Agency Issues Update on Gadolinium Contrast Agents
News | Contrast Media| August 29, 2017
August 29, 2017 — The European Medicines Agency (EMA) issued a final opinion that recommended restricting the use of
Philips is partnering with HeartFlow to co-develop new FFR-CT and FFR-angiography imaging technologies.
News | FFR Technologies| August 28, 2017
August 28, 2017 — Philips Healthcare and HeartFlow Inc.
St. Cloud Hospital Installs Toshiba Aquilion One Genesis CT for Emergency Department
News | Computed Tomography (CT)| August 23, 2017
Central Minnesota residents now have access to advanced computed tomography (CT) technology that is safe and fast at St...
Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Cardiac Imaging| August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
ISMRM Issues Guidelines for MRI Gadolinium Contrast Agents
News | Magnetic Resonance Imaging (MRI)| August 15, 2017
The International Society for Magnetic Resonance in Medicine (ISMRM) has provided new guidance in the use of contrast...
Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on HeartFlow FFRct Analysis
News | FFR Technologies| August 09, 2017
HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical policy for the...
Overlay Init